Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Solid Therapeutics ApS
APS
Active
CVR 43007068
Ole Maaløes Vej 3
Research and experimental development on natural sciences and engineering · NACE 7210
Est. 2022
3 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2024
DKK -4,2M
+54% vs 2023
EBITDA margin
172.0%
-73% vs 2023
Equity ratio
-99.9%
Financial strength
Net profit 2024
DKK -6,8M
-94% vs 2023
EBITDA — year on year
DKK millions
0M
-0M
-1M
-1M
-1M
-1M
2022
-4M
-300%
2023
-7M
-75%
2024
Key figures
Annual report 2024
Revenue
DKK -4,2M
+54%
EBITDA
DKK -7,2M
-73%
Net profit
DKK -6,8M
-94%
Total assets
DKK 11M
+2%
Equity
DKK -11M
-159%
Employees
3
—
Company information
Legal name
Solid Therapeutics ApS
CVR number
43007068
Legal form
Anpartsselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
21. januar 2022
Share capital
DKK 40.000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør i forening med et bestyrelsesmedlem eller af den samlede bestyrelse i forening.
Company purpose
Selskabets formål er at udøve aktiviteter indenfor fund af lægemidler og udvikling heraf.
Contact
Address
Ole Maaløes Vej 3
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Research and experimental development on natural sciences and engineering
Companies in København
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2022
-3M
2023
-4M
2024
EBITDA
DKK millions
0M
-0M
-1M
-1M
-1M
-1M
2022
-4M
2023
-7M
2024
Income statement
DKK thousands
Item
2022
2023
2024
Revenue
-398
-2.739
-4.214
Staff expenses
-364
-1.454
-3.033
EBITDA
-762
-4.193
-7.247
Depreciation & amort.
-0
-0
-0
EBIT
-762
-4.193
-7.247
Net financials
-113
-167
-1.065
Profit before tax
-875
-4.360
-8.312
Tax
-78
-877
-1.554
Net profit
-797
-3.483
-6.758
Balance sheet
DKK thousands
Item
2022
2023
2024
Total assets
3.575
10.813
11.004
Equity
-757
-4.240
-10.998
Long-term debt
4.093
14.256
20.308
Short-term debt
239
797
1.694
Total debt
4.332
15.053
22.002
Financial ratios
5-year trend
EBITDA margin
-724705900.0%
This company
15.8%
Market median
-4586746303% vs market
2022
2024
Equity ratio
-99.9%
This company
38.2%
Market median
-362% vs market
2022
2024
Return on equity
-675820700.0%
This company
18.4%
Market median
-3672938687% vs market
2022
2024
Net profit margin
-675820700.0%
This company
8.1%
Market median
-8343465532% vs market
2022
2024
Asset turnover
-0.38×
This company
1.12×
Market median
-134% vs market
2022
2024
Debt / equity
2.00×
This company
0.62×
Market median
-223% vs market
2022
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-21 – 2022-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Age
Other directorships
TM
Thomas Michael Frimurer
Founder
Founder
2022
—
—
Board of directors
Non-executive oversight
Name
Role
Member since
Age
Other directorships
CH
Claus Haase
Board of Directors
2022
—
—
TW
Thue Walter Schwartz
Board of Directors
2022
—
—
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Frimurer Holdings ApS
Company
20.0%
20.0%
2022
Receptor Holding ApS
Company
20.0%
20.0%
2022
Anne Mette Hyldgaard Trauelsen
Individual
20.0%
20.0%
2023
Hagop Youssoufian
Individual
10.0%
10.0%
2023
Haase Invest ApS
Company
10.0%
10.0%
2022
Stine Helene Falsig Petersen
Individual
10.0%
10.0%
2023
John Sørensen Haurum
Individual
10.0%
10.0%
2022
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Solid Therapeutics ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Thomas Michael Frimurer
Founder
0 companies
Claus Haase
Board of Directors
0 companies
Thue Walter Schwartz
Board of Directors
0 companies